These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29954870)

  • 1. HIV viral load point-of-care testing: the what, the whys and the wherefores.
    Brook G
    Sex Transm Infect; 2018 Sep; 94(6):394-395. PubMed ID: 29954870
    [No Abstract]   [Full Text] [Related]  

  • 2. Point-of-care viral load testing and differentiated HIV care.
    Dorward J; Drain PK; Garrett N
    Lancet HIV; 2018 Jan; 5(1):e8-e9. PubMed ID: 29290227
    [No Abstract]   [Full Text] [Related]  

  • 3. Health care industries' perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay.
    Elbeik T; Loftus RA; Beringer S
    Expert Rev Mol Diagn; 2002 May; 2(3):275-85. PubMed ID: 12050866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral load monitoring in resource-limited settings: a medical and public health priority.
    Ford N; Roberts T; Calmy A
    AIDS; 2012 Aug; 26(13):1719-20. PubMed ID: 22874478
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring treatment: at what cost?
    Cohen J
    Science; 2004 Jun; 304(5679):1936. PubMed ID: 15218140
    [No Abstract]   [Full Text] [Related]  

  • 8. [Looking at the HIV test. Qualitative virus detection a cost-effective alternative?].
    Scharmer U
    MMW Fortschr Med; 2000; 142(3 Suppl):38. PubMed ID: 10893966
    [No Abstract]   [Full Text] [Related]  

  • 9. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
    Bryant L; Smith N; Keiser P
    J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health. Getting HIV treatment to the most people.
    Lynch S; Ford N; van Cutsem G; Bygrave H; Janssens B; Decroo T; Andrieux-Meyer I; Roberts T; Balkan S; Casas E; Ferreyra C; Bemelmans M; Cohn J; Kahn P; Goemaere E
    Science; 2012 Jul; 337(6092):298-300. PubMed ID: 22798404
    [No Abstract]   [Full Text] [Related]  

  • 11. Access to HIV viral load testing.
    Baker R
    BETA; 1996 Sep; ():5. PubMed ID: 11363886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence clubs for long-term provision of antiretroviral therapy: cost-effectiveness and access analysis from Khayelitsha, South Africa.
    Bango F; Ashmore J; Wilkinson L; van Cutsem G; Cleary S
    Trop Med Int Health; 2016 Sep; 21(9):1115-23. PubMed ID: 27300077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care diagnostics: extending the laboratory network to reach the last mile.
    Drain PK; Rousseau C
    Curr Opin HIV AIDS; 2017 Mar; 12(2):175-181. PubMed ID: 28079591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply.
    Avram CM; Greiner KS; Tilden E; Caughey AB
    Am J Obstet Gynecol; 2020 Jul; 223(1):142. PubMed ID: 32194025
    [No Abstract]   [Full Text] [Related]  

  • 15. Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies.
    Pham QD; Wilson DP; Nguyen TV; Do NT; Truong LX; Nguyen LT; Zhang L
    J Antimicrob Chemother; 2016 May; 71(5):1367-79. PubMed ID: 26869689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.
    Roberts T; Cohn J; Bonner K; Hargreaves S
    Clin Infect Dis; 2016 Apr; 62(8):1043-8. PubMed ID: 26743094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the SAMBA I and II HIV-1 Semi-Q Tests for viral load monitoring at the point-of-care.
    Goel N; Ritchie AV; Mtapuri-Zinyowera S; Zeh C; Stepchenkova T; Lehga J; De Ruiter A; Farleigh LE; Edemaga D; So R; Sembongi H; Wisniewski C; Nadala L; Schito M; Lee H
    J Virol Methods; 2017 Jun; 244():39-45. PubMed ID: 28274744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Whole-Blood Alere Q NAT Point-of-Care RNA Assay for HIV-1 Viral Load Monitoring in a Primary Health Care Setting in Mozambique.
    Jani IV; Meggi B; Vubil A; Sitoe NE; Bhatt N; Tobaiwa O; Quevedo JI; Loquiha O; Lehe JD; Vojnov L; Peter TF
    J Clin Microbiol; 2016 Aug; 54(8):2104-8. PubMed ID: 27252459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Need for point-of-care HIV molecular diagnostic technologies in resource-limited settings. Proceedings from the workshop "Novel Technologies in Rapid HIV-1 Viral Detection".
    J Infect Dis; 2010 Apr; 201 Suppl 1():S1-84. PubMed ID: 20225953
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes and cost analysis of 3 operational models for rapid HIV testing services in an academic inner-city emergency department.
    Hsieh YH; Jung JJ; Shahan JB; Pollack HA; Hairston HS; Moring-Parris D; Kelen GD; Rothman RE
    Ann Emerg Med; 2011 Jul; 58(1 Suppl 1):S133-9. PubMed ID: 21684392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.